- |||||||||| Trial completion, Enrollment change: Analysis of Lyme Disease Lesions (clinicaltrials.gov) - Dec 3, 2018
P=N/A, N=27, Completed, Active, not recruiting --> Completed | N=132 --> 59 Recruiting --> Completed | N=60 --> 27
- |||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Safety and Tolerability Study of Antimicrobial TheraGauze for Skin Abscess (clinicaltrials.gov) - Aug 30, 2018
P1/2, N=6, Completed, Terminated --> Completed Not yet recruiting --> Completed | N=100 --> 6 | Trial completion date: Apr 2019 --> Aug 2017 | Trial primary completion date: Oct 2018 --> Aug 2017
- |||||||||| Phase classification: Analysis of Lyme Disease Lesions (clinicaltrials.gov) - Mar 30, 2018
P, N=60, Recruiting, Recruiting --> Completed | Trial completion date: Jun 2018 --> Dec 2017 Phase classification: P=N/A --> P
- |||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Registry for the Atopic Dermatitis Research Network (clinicaltrials.gov) - Mar 2, 2018
P=N/A, N=3386, Completed, Active, not recruiting --> Completed Recruiting --> Completed | N=2600 --> 3386 | Trial primary completion date: Feb 2020 --> Feb 2018 | Trial completion date: Feb 2020 --> Feb 2018
- |||||||||| mupirocin / Generic mfg.
Trial completion, Trial completion date: HOME2DS: Individualized vs. Household MRSA Decolonization (clinicaltrials.gov) - Feb 28, 2018 P=N/A, N=671, Completed, Recruiting --> Completed | N=2600 --> 3386 | Trial primary completion date: Feb 2020 --> Feb 2018 | Trial completion date: Feb 2020 --> Feb 2018 Enrolling by invitation --> Completed | Trial completion date: Dec 2017 --> Nov 2017
- |||||||||| Trial initiation date, Trial primary completion date: Improving Blood Safety and HIV Testing in Brazil (clinicaltrials.gov) - Jan 18, 2018
P=N/A, N=11900, Completed, Phase classification: P1/2 --> P2 Initiation date: Mar 2012 --> Aug 2012 | Trial primary completion date: Sep 2013 --> May 2013
- |||||||||| Mycamine (micafungin) / Astellas
Trial primary completion date: Study of FK463 for the Treatment of Invasive Aspergillosis (clinicaltrials.gov) - Jan 10, 2018 P2, N=326, Completed, Initiation date: Mar 2012 --> Aug 2012 | Trial primary completion date: Sep 2013 --> May 2013 Trial primary completion date: Dec 2002 --> Jan 2002
- |||||||||| Trial completion: Protocol TARC-ABPA (clinicaltrials.gov) - Nov 14, 2017
P=N/A, N=29, Completed, Trial primary completion date: Dec 2002 --> Jan 2002 Active, not recruiting --> Completed
- |||||||||| flucloxacillin sodium / Generic mfg.
Enrollment change, Trial termination: DANCE: Duration of ANtibiotic Therapy for CEllulitis (clinicaltrials.gov) - Oct 9, 2017 P4, N=151, Terminated, N=60 --> 27 | Recruiting --> Terminated; Sponsor chose to close N=316 --> 151 | Active, not recruiting --> Terminated; Budget exceeded
- |||||||||| flucloxacillin sodium / Generic mfg.
Enrollment closed, Trial primary completion date: DANCE: Duration of ANtibiotic Therapy for CEllulitis (clinicaltrials.gov) - Aug 16, 2017 P4, N=316, Active, not recruiting, Active, not recruiting --> Completed | Trial primary completion date: Mar 2017 --> Jul 2017 Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2018 --> Jul 2017
- |||||||||| prednisone / Generic mfg.
Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date: The Use of Oral Steroids in the Treatment of Cellulitis (clinicaltrials.gov) - Jul 25, 2017 P2, N=0, Withdrawn, Not yet recruiting --> Active, not recruiting | Trial primary completion date: Jun 2017 --> Oct 2018 N=35 --> 0 | Initiation date: Sep 2009 --> Jan 2010 | Not yet recruiting --> Withdrawn | Trial primary completion date: Mar 2010 --> Aug 2010
- |||||||||| tigecycline / Generic mfg.
Trial completion: TIGER: Tygacil Drug Use Investigation (clinicaltrials.gov) - Jul 17, 2017 P=N/A, N=100, Completed, N=35 --> 0 | Initiation date: Sep 2009 --> Jan 2010 | Not yet recruiting --> Withdrawn | Trial primary completion date: Mar 2010 --> Aug 2010 Active, not recruiting --> Completed
- |||||||||| Remicade (infliximab) / Merck (MSD), Mitsubishi Tanabe, J&J
Trial withdrawal: Topical Infliximab in Autoimmune Eyes With Keratoprosthesis (clinicaltrials.gov) - Apr 7, 2017 P1/2, N=0, Withdrawn, Trial primary completion date: Oct 2016 --> Aug 2017 Enrolling by invitation --> Withdrawn
- |||||||||| Decadron (dexamethasone) / Merck (MSD)
Enrollment change, Trial termination, Trial primary completion date: Use of Corticosteroids in Children With Cellulitis (clinicaltrials.gov) - Mar 13, 2017 P=N/A, N=19, Terminated, Active, not recruiting --> Completed N=124 --> 19 | Recruiting --> Terminated | Trial primary completion date: Oct 2016 --> Mar 2016; Calculated sample size not achieved
- |||||||||| tigecycline / Generic mfg.
Trial primary completion date: TIGER: Tygacil Drug Use Investigation (clinicaltrials.gov) - Mar 1, 2017 P=N/A, N=100, Active, not recruiting, N=124 --> 19 | Recruiting --> Terminated | Trial primary completion date: Oct 2016 --> Mar 2016; Calculated sample size not achieved Trial primary completion date: Feb 2017 --> May 2017
- |||||||||| pentoxifylline / Generic mfg.
Trial completion, Trial initiation date, Trial primary completion date: Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis (clinicaltrials.gov) - Jan 26, 2017 P2/3, N=164, Completed, Recruiting --> Completed | N=12 --> 15 | Trial primary completion date: Dec 2017 --> Jan 2017 Active, not recruiting --> Completed | Initiation date: Jan 2011 --> Mar 2012 | Trial primary completion date: Jan 2014 --> Jan 2015
- |||||||||| gentamicin sulfate / Generic mfg.
Trial completion, Enrollment change, Trial initiation date, Trial primary completion date: PAGELEC: WR 279,396 for the Treatment of Cutaneous Leishmaniasis (clinicaltrials.gov) - Jan 26, 2017 P2, N=18, Completed, Active, not recruiting --> Completed | Initiation date: Jan 2011 --> Mar 2012 | Trial primary completion date: Jan 2014 --> Jan 2015 Active, not recruiting --> Completed | N=30 --> 18 | Initiation date: Jun 2014 --> Sep 2013 | Trial primary completion date: Sep 2017 --> Dec 2015
- |||||||||| flucloxacillin sodium / Generic mfg.
Trial primary completion date: DANCE: Duration of ANtibiotic Therapy for CEllulitis (clinicaltrials.gov) - Jan 24, 2017 P4, N=316, Recruiting, Recruiting --> Completed Trial primary completion date: Apr 2017 --> Jan 2018
- |||||||||| tigecycline / Generic mfg.
Trial primary completion date: TIGER: Tygacil Drug Use Investigation (clinicaltrials.gov) - Nov 4, 2016 P=N/A, N=100, Active, not recruiting, Recruiting --> Completed | Trial primary completion date: Jun 2017 --> Oct 2016 Trial primary completion date: Jun 2017 --> Jan 2017
|